Patients News | pharmaphorum

News

Close-up of the fag of Germany against a blue sky.

Germany confirms booster COVID jabs will start in September

Germany's health ministry has said it will start offering booster COVID-19 vaccines to vulnerable people from next month, amid concerns about rising cases of the delta variant of the corona

News

AZ says second COVID jab dose isn't linked to rare clot reac...

A new analysis has suggested that the rare blood clot side effects linked to AstraZeneca's COVID-19 vaccine Vaxzevria don't occur after a second dose.

News

Rapid COVID immune status test launched in UK, Ireland

You've had your two COVID-19 jabs, but are you actually protected against infection?

News

Resourceful or risky-The UKs controversial COVID-19 vaccine strategy

Study finds jabs cut severe variant COVID disease after one ...

A real-world study carried out in Canada has found that COVID-19 vaccines from AstraZeneca, Pfizer/BioNTech and Moderna reduce the chances of being hospitalised or dying from variants of co

News

What HCPs think about COVID-19s impact on cancer diagnosis and treatment

UK funds 'long COVID' research drive as restrictions ease

The UK government has provided almost £20 million ($27 million) in funding for 15 research projects aiming to look into the causes of long COVID, improve diagnosis and find new treatments f

News

FDA adds warning of rare neurological side effect to J&J COV...

The FDA has added a new warning on the Johnson & Johnson COVID-19 vaccine, saying the shot has been linked to a serious but rare side effect – Guillain-Barré syndrome – that can cause m

Germany confirms booster COVID jabs will start in September

AZ says second COVID jab dose isn't linked to rare clot reac...

Rapid COVID immune status test launched in UK, Ireland

Study finds jabs cut severe variant COVID disease after one ...

UK funds 'long COVID' research drive as restrictions ease

FDA adds warning of rare neurological side effect to J&J COV...

Amazon puts $100m into global health drive

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks